35679529 2022-12-31 35679529 2021-12-31 35679529 2020-12-31 35679529 2024-12-31 35679529 2023-12-31 35679529 2024-01-01 fsa:ContributedCapitalMember 35679529 2024-01-01 fsa:ReserveForNetRevaluationAccordingToEquityMethodMember 35679529 2024-01-01 fsa:ReserveForDevelopmentExpenditureMember 35679529 2024-01-01 fsa:RetainedEarningsMember 35679529 2024-01-01 fsa:ProposedDividendRecognisedInEquityMember 35679529 2024-12-31 fsa:ContributedCapitalMember 35679529 2024-12-31 fsa:ReserveForNetRevaluationAccordingToEquityMethodMember 35679529 2024-12-31 fsa:ReserveForDevelopmentExpenditureMember 35679529 2024-12-31 fsa:RetainedEarningsMember 35679529 2024-12-31 fsa:ProposedDividendRecognisedInEquityMember 35679529 2024-01-01 fsa:CompletedDevelopmentProjectsMember 35679529 2024-12-31 fsa:CompletedDevelopmentProjectsMember 35679529 2024-01-01 fsa:FixturesFittingsToolsAndEquipmentMember 35679529 2024-01-01 fsa:LeaseholdImprovementsMember 35679529 2024-12-31 fsa:FixturesFittingsToolsAndEquipmentMember 35679529 2024-12-31 fsa:LeaseholdImprovementsMember 35679529 2024-01-01 fsa:InvestmentsInGroupEnterprisesMember 35679529 2023-01-01 fsa:InvestmentsInGroupEnterprisesMember 35679529 2024-12-31 fsa:InvestmentsInGroupEnterprisesMember 35679529 2023-12-31 fsa:InvestmentsInGroupEnterprisesMember 35679529 2024-12-31 1 fsa:SubsidiaryMember 35679529 2024-12-31 2 fsa:SubsidiaryMember 35679529 2024-12-31 fsa:OtherLongtermPayablesMember 35679529 2023-12-31 fsa:OtherLongtermPayablesMember 35679529 2024-12-31 fsa:OtherShorttermPayablesMember 35679529 2023-12-31 fsa:OtherShorttermPayablesMember 35679529 2024-01-01 2024-12-31 35679529 2024-01-01 2024-12-31 1 35679529 2024-01-01 2024-12-31 memberOfBoardIdentifier_executive_board_1 35679529 2024-01-01 2024-12-31 memberOfBoardIdentifier_executive_board_2 35679529 2024-01-01 2024-12-31 memberOfBoardIdentifier_executive_board_3 35679529 2024-01-01 2024-12-31 memberOfBoardIdentifier_board_of_director_1 35679529 2024-01-01 2024-12-31 memberOfBoardIdentifier_board_of_director_2 35679529 2024-01-01 2024-12-31 memberOfBoardIdentifier_board_of_director_3 35679529 2024-01-01 2024-12-31 2 35679529 2022-01-01 2022-12-31 35679529 2021-01-01 2021-12-31 35679529 2020-01-01 2020-12-31 35679529 2023-01-01 2023-12-31 35679529 2024-01-01 2024-12-31 fsa:ContributedCapitalMember 35679529 2024-01-01 2024-12-31 fsa:ReserveForNetRevaluationAccordingToEquityMethodMember 35679529 2024-01-01 2024-12-31 fsa:ReserveForDevelopmentExpenditureMember 35679529 2024-01-01 2024-12-31 fsa:RetainedEarningsMember 35679529 2024-01-01 2024-12-31 fsa:ProposedDividendRecognisedInEquityMember 35679529 2024-01-01 2024-12-31 fsa:CompletedDevelopmentProjectsMember 35679529 2024-01-01 2024-12-31 fsa:FixturesFittingsToolsAndEquipmentMember 35679529 2024-01-01 2024-12-31 fsa:LeaseholdImprovementsMember 35679529 2024-01-01 2024-12-31 fsa:InvestmentsInGroupEnterprisesMember 35679529 2023-01-01 2023-12-31 fsa:InvestmentsInGroupEnterprisesMember 35679529 2024-01-01 2024-12-31 1 fsa:SubsidiaryMember 35679529 2024-01-01 2024-12-31 2 fsa:SubsidiaryMember iso4217:DKK pure Årsrapport 33771231 PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab Strandvejen 44 2900 Hellerup 2024-01-01 2023-01-01 2024-12-31 2023-12-31 35679529 Omnidocs A/S Wilders Plads 15A 1403 København K København +45 70 20 72 47 www.omnidocs.com 2014-03-06 PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab 33771231 Strandvejen 44 2900 Hellerup Denmark 39 45 39 45 koebenhavn@pwc.dk 2025-03-28 Jeppe Schytte Hansen Regnskabsklasse B Revisionspåtegning The Executive Board and Board of Directors have today considered and adopted the Annual Report of Omnidocs A/S for the financial year 1 January - 31 December 2024. The Annual Report is prepared in accordance with the Danish Financial Statements Act. In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2024 of the Company and of the results of the Company operations for 2024. We recommend that the Annual Report be adopted at the Annual General Meeting. 2025-03-28 Copenhagen Jeppe Schytte-Hansen CEO Jakob Bjersing CFO Morten Hald Mortensen CPO Wessel Geoff Ploegmakers Chairman Christian Lund Carl Johan Bergkvist To the shareholders of Omnidocs A/S Opinion In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2024 and of the results of the Company´s operations for the financial year 1 January - 31 December 2024 in accordance with the Danish Financial Statements Act. We have audited the Financial Statements of Omnidocs A/S for the financial year 1 January - 31 December 2024, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies (”the Financial Statements”). Basis for Opinion We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the ”Auditor’s responsibilities for the audit of the Financial Statements” section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion. Management is responsible for the preparation of financial statements that give a true and fair view in accordance with the Danish Financial Statements Act, and for such internal control as Management determines is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the Financial Statements, Management is responsible for assessing the Company´s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the Financial Statements unless Management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so. Our objectives are to obtain reasonable assurance about whether the Financial Statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Financial Statements. As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgement and maintain professional scepticism throughout the audit. We also: Identify and assess the risks of material misstatement of the Financial Statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company´s internal control. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Management. Conclude on the appropriateness of Management’s use of the going concern basis of accounting in preparing the Financial Statements and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company´s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the Financial Statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Company to cease to continue as a going concern. Evaluate the overall presentation, structure and contents of the Financial Statements, including the disclosures, and whether the Financial Statements represent the underlying transactions and events in a manner that gives a true and fair view. Plan and perform the audit to obtain sufficient appropriate audit evidence regarding the consolidated financial information of the entities or business units as a basis for forming an opinion on the Financial Statements. We are responsible for the direction, supervision and review of the audit work performed. We remain solely responsible for our audit opinion. We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit. Hellerup 2025-03-28 PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab Henrik Aslund Pedersen State Authorised Public Accountant mne17120 Carsten Blicher State Authorised Public Accountant mne16560 5693000 3901000 3562000 449000 115000 23000 5511000 3132000 2794000 59175000 50649000 51031000 37000 0 40000 0 -34000 11186000 8175000 7043000 67 57 52 0.078 0.135 0.096 0.077 0.07 0.111 0.204 0.189 0.161 0.138 0.485 0.506 0.569 0.412 0.392 49574804 54518459 44818948 45160850 697416 707530 4058440 8650079 728595 109350 981244 659562 133308 704849 5634971 8714142 1084801 2587032 4550170 6127110 11806678 0 2000000 0 837137 58284 -10093645 6068826 2598936 503240 2598936 503240 27220 67288 33403 4383 60623 71671 1074421 345570 1074421 345570 3733980 920481 22529514 24513916 3000000 2500000 7524114 5760635 839222 2857563 946535 17500 34839385 35649614 13468488 27278950 48307873 62928564 52041853 63849045 550000 550000 1024421 187284 2027170 392527 154688 11882976 2000000 0 5756279 13012787 541981 77580 541981 77580 2735319 2707313 2735319 2707313 6218292 3696551 0 6966317 620400 2509452 4937197 5184103 31232385 29694942 43008274 48051365 45743593 50758678 52041853 63849045 550000 187284 392527 11882976 0 0 0 0 -11806678 0 0 837137 0 1713033 2000000 0 0 1634643 -1634643 0 550000 1024421 2027170 154688 2000000 The company’s main activity consists in providing services related to implementation of Brand Management and Productivity Tools for Microsoft Office. Our services include template development, design projects, customer success activities, change management and consultancy with a narrow focus on alignment of the Corporate Visual Identity and on how users can save time when creating documents, presentations and mails. We develop and sell our of own software components as well as 3rd party software applications, such as Templafy. 40400061 41112105 2570731 2527191 506421 485060 1341735 1036494 44818948 45160850 68 68 0 18074 629381 641488 351863 0 981244 659562 620400 2509452 464401 77580 1084801 2587032 503240 2745430 3248670 0 649734 649734 2598936 Development projects relate to development of software products for sale. 2322334 65708 0 36634 2322334 102342 2255046 61325 40068 7614 2295114 68939 27220 33403 108500 116000 7500 0 66000 7500 50000 108500 237070 129000 0 -1280 1022581 109350 235230 0 1024421 237070 1074421 345570 Documotor ApS Copenhagen 100 1074421 972809 Omnidocs Inc. USA 100 0 49772 Investments in subsidiaries are specified as follows: 0 0 2735319 2707313 2735319 2707313 4937197 5184103 Payments due within 1 year are recognised in short-term debt. Other debt is recognised in long-term debt. The debt falls due for payment as specified below: Other payables Charges and security The following assets have been placed as security with bankers: Mortgage deeds registered to the mortgagor totalling TDKK 3,400, providing security on property, plant and equipment and trade receivables at a total carrying amount of 22556734 24581204 Rental and lease obligations Lease obligations under operating leases. Total future lease payments: Within 1 year 1624513 1564033 Between 1 and 5 years 0 1564033 Total 1624513 3128066 Other contingent liabilities The group companies are jointly and severally liable for tax on the jointly taxed incomes etc of the Group. The total amount of corporation tax payable is disclosed in the Annual Report of Omnidocs Holding ApS, which is the management company of the joint taxation purposes. Moreover, the group companies are jointly and severally liable for Danish withholding taxes by way of dividend tax, tax on royalty payments and tax on unearned income. Any subsequent adjustments of corporation taxes and withholding taxes may increase the Company’s liability. The Annual Report of Omnidocs A/S for 2024 has been prepared in accordance with the provisions of the Danish Financial Statements Act applying to enterprises of reporting class B as well as selected rules applying to reporting class C. The accounting policies applied remain unchanged from last year. The Financial Statements for 2024 are presented in DKK. true With reference to section 112 of the Danish Financial Statements Act and to the consolidated financial statements for 2024 of Omnidocs Group ApS, the Company has not prepared consolidated financial statements. 1 Revenues are recognised in the income statement as earned. Furthermore, value adjustments of financial assets and liabilities measured at fair value or amortised cost are recognised. Moreover, all expenses incurred to achieve the earnings for the year are recognised in the income statement. Assets are recognised in the balance sheet when it is probable that future economic benefits attributable to the asset will flow to the Company, and the value of the asset can be measured reliably. Liabilities are recognised in the balance sheet when it is probable that future economic benefits will flow out of the Company, and the value of the liability can be measured reliably. Assets and liabilities are initially measured at cost. Subsequently, assets and liabilities are measured as described for each item below. Transactions in foreign currencies are translated at the exchange rates at the dates of transaction. Gains and losses arising due to differences between the transaction date rates and the rates at the dates of payment are recognised in financial income and expenses in the income statement. Receivables, payables and other monetary items in foreign currencies that have not been settled at the balance sheet date are translated at the exchange rates at the balance sheet date. Any differences between the exchange rates at the balance sheet date and the rates at the time when the receivable or the debt arose are recognised in financial income and expenses in the income statement. Services are recognised at the rate of completion of the service to which the contract relates by using the percentage-of-completion method, which means that revenue equals the selling price of the service completed for the year. This method is applied when total revenues and expenses in respect of the service and the stage of completion at the balance sheet date can be measured reliably, and it is probable that the economic benefits, including payments, will flow to the Company. The stage of completion is determined on the basis of the ratio between the expenses incurred and the total expected expenses of the service. Revenue is measured at the consideration received and is recognised exclusive of VAT and net of discounts relating to sales. Other external expenses comprise indirect production costs and expenses for premises, sales as well as office expenses, etc. Other external expenses also include research and development costs that do not qualify for capitalisation. With reference to section 32 of the Danish Financial Statements Act, gross profit/loss is calculated as a summary of revenue, work on own account recognised in assets, other operating income and other external expenses. Staff expenses comprise wages and salaries as well as payroll expenses. Amortisation, depreciation and impairment losses comprise amortisation, depreciation and impairment of intangible assets and property, plant and equipment. Other operating income and other operating expenses comprise items of a secondary nature to the main activities of the Company, including gains and losses on the sale of intangible assets and property, plant and equipment. The item “Income from investments in subsidiaries” in the income statement includes the proportionate share of the profit for the year. Financial income and expenses are recognised in the income statement at the amounts relating to the financial year. Tax for the year consists of current tax for the year and changes in deferred tax for the year. The tax attributable to the profit for the year is recognised in the income statement, whereas the tax attributable to equity transactions is recognised directly in equity. The Company is jointly taxed with wholly owned Danish and foreign subsidiaries. The tax effect of the joint taxation is allocated to enterprises in proportion to their taxable incomes. Development costs for clearly defined and completed development projects are capitalized and amortized over the expected life, which is typically assessed at 5 years. Other development costs and costs for internally accrued rights are recognized in the income statement as costs in the year of acquisition. Property, plant and equipment are measured at cost less accumulated depreciation and less any accumulated impairment losses. Cost comprises the cost of acquisition and expenses directly related to the acquisition up until the time when the asset is ready for use. Depreciation based on cost reduced by any residual value is calculated on a straight-line basis over the expected useful lives of the assets, which are: Other fixtures and fittings, tools and equipment 5 years The fixed assets’ residual values are determined at nil. Depreciation period and residual value are reassessed annually. The carrying amounts of intangible assets and property, plant and equipment and investments are reviewed on an annual basis to determine whether there is any indication of impairment other than that expressed by amortisation and depreciation. If so, the asset is written down to its lower recoverable amount. Investments in subsidiaries are recognised and measured under the equity method. The item “Investments in subsidiaries” in the balance sheet include the proportionate ownership share of the net asset value of the enterprises calculated on the basis of the fair values of identifiable net assets at the time of acquisition. The total net revaluation of investments in subsidiaries is transferred upon distribution of profit to “Reserve for net revaluation under the equity method“ under equity. The reserve is reduced by dividend distributed to the Parent Company and adjusted for other equity movements in the subsidiaries. Subsidiaries with a negative net asset value are recognised at DKK 0. Any legal or constructive obligation of the Parent Company to cover the negative balance of the enterprise is recognised in provisions. Receivables are measured in the balance sheet at the lower of amortised cost and net realisable value, which corresponds to nominal value less provisions for bad debts. Contract work in progress is measured at selling price of the work performed calculated on the basis of the stage of completion. The stage of completion is measured by the proportion that the contract expenses incurred to date bear to the estimated total contract expenses. Where it is probable that total contract expenses will exceed total revenues from a contract, the expected loss is recognised as an expense in the income statement. Payments received on account are set off against the selling price. The individual contracts are classified as receivables when the net selling price is positive and as liabilities when the net selling price is negative. Expenses relating to sales work and the winning of contracts are recognised in the income statement as incurred. Prepayments comprise prepaid expenses concerning insurance premiums and subscriptions. Dividend distribution proposed by Management for the year is disclosed as a separate equity item. Deferred income tax is measured using the balance sheet liability method in respect of temporary differences arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes on the basis of the intended use of the asset and settlement of the liability, respectively. Deferred tax assets are measured at the value at which the asset is expected to be realised, either by elimination in tax on future earnings or by set-off against deferred tax liabilities within the same legal tax entity. Deferred tax is measured on the basis of the tax rules and tax rates that will be effective under the legislation at the balance sheet date when the deferred tax is expected to crystallise as current tax. Any changes in deferred tax due to changes to tax rates are recognised in the income statement or in equity if the deferred tax relates to items recognised in equity. Current tax liabilities and receivables are recognised in the balance sheet as the expected taxable income for the year adjusted for tax on taxable incomes for prior years and tax paid on account. Extra payments and repayment under the on-account taxation scheme are recognised in the income statement in financial income and expenses. Debts are measured at amortised cost, substantially corresponding to nominal value. Deferred income comprises payments received in respect of income in subsequent years. Return on assets Profit/loss of primary operations x 100 / Total assets at year end Solvency ratio Equity at year end x 100 / Total assets at year end Return on equity Net profit for the year x 100 / Average equity